Andersen, P., Tampakakis, E., Jimenez, D.V., Kannan, S., Miya- moto, M., Shin, H.K., Saberi, A., Murphy, S., Sulistio, E., Chelko, S.P., et al. (2018). Precardiac organoids form two heart fields via Bmp/Wnt signaling. Nat. Commun. 9, 3140.
Arthur, H.M., Ure, J., Smith, A.J., Renforth, G., Wilson, D.I., Tor-sney, E., Charlton, R., Parums, D.V., Jowett, T., Marchuk, D.A., et al. (2000). Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev. Biol. 217, 42–53.
Barnes, R.M., Firulli, B.A., Conway, S.J., Vincentz, J.W., and Firulli, A.B. (2010). Analysis of the Hand1 cell lineage reveals novel contri- butions to cardiovascular, neural crest, extra-embryonic, and lateral mesoderm derivatives. Dev. Dyn. 239, 3086–3097.
Boeva, V., Louis-Brennetot, C., Peltier, A., Durand, S., Pierre-Eu- gene, C., Raynal, V., Etchevers, H.C., Thomas, S., Lermine, A., Dau- digeos-Dubus, E., et al. (2017). Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. Nat. Genet. 49,1408–1413.
Bruneau, B.G., Logan, M., Davis, N., Levi, T., Tabin, C.J., Seidman, J.G., and Seidman, C.E. (1999). Chamber-specific cardiac expres- sion of Tbx5 and heart defects in Holt-Oram syndrome. Dev. Biol. 211, 100–108.
Buikema, J.W., Lee, S., Goodyer, W.R., Maas, R.G., Chirikian, O., Li, G., Miao, Y., Paige, S.L., Lee, D., Wu, H., et al. (2020). Wnt activa- tion and reduced cell-cell contact synergistically induce massive expansion of functional human iPSC-derived cardiomyocytes. Cell Stem Cell 27, 50–63.e55.
Burridge, P.W., Keller, G., Gold, J.D., and Wu, J.C. (2012). Produc- tion of de novo cardiomyocytes: human pluripotent stem cell dif- ferentiation and direct reprogramming. Cell Stem Cell 10, 16–28.
Cai, C.L., Liang, X., Shi, Y., Chu, P.H., Pfaff, S.L., Chen, J., and Evans, S. (2003). Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 5, 877–889.
Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127, 469–480.
Consortium, E.P. (2012). An integrated encyclopedia of DNA ele- ments in the human genome. Nature 489, 57–74.
Cserjesi, P., Brown, D., Lyons, G.E., and Olson, E.N. (1995). Expres- sion of the novel basic helix-loop-helix gene eHAND in neural crest derivatives and extraembryonic membranes during mouse development. Dev. Biol. 170, 664–678.
Cui, Y.L., Zheng, Y.X., Liu, X.X., Yan, L.Y., Fan, X.Y., Yong, J., Hu,Y.Q., Dong, J., Li, Q.Q., Wu, X.L., et al. (2019). Single-cell transcrip- tome analysis maps the developmental track of the human heart. Cell Rep. 26, 1934.
de Soysa, T.Y., Ranade, S.S., Okawa, S., Ravichandran, S., Huang, Y., Salunga, H.T., Schricker, A., del Sol, A., Gifford, C.A., and Srivas- tava, D. (2019). Single-cell analysis of cardiogenesis reveals basis for organ-level developmental defects. Nature 572, 120.
Devalla, H.D., Schwach, V., Ford, J.W., Milnes, J.T., El-Haou, S., Jackson, C., Gkatzis, K., Elliott, D.A., Chuva de Sousa Lopes, S.M., Mummery, C.L., et al. (2015). Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology. EMBO Mol. Med. 7, 394–410.
Durbin, A.D., Zimmerman, M.W., Dharia, N.V., Abraham, B.J., In- iguez, A.B., Weichert-Leahey, N., He, S., Krill-Burger, J.M., Root, D.E., Vazquez, F., et al. (2018). Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry. Nat. Genet. 50, 1240–1246.
Firulli, A.B., McFadden, D.G., Lin, Q., Srivastava, D., and Olson, E.N. (1998). Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1. Nat. Genet. 18, 266–270.
Friedman, C.E., Nguyen, Q., Lukowski, S.W., Helfer, A., Chiu, H.S., Miklas, J., Levy, S., Suo, S., Han, J.J., Osteil, P., et al. (2018). Single- cell transcriptomic analysis of cardiac differentiation from human PSCs reveals HOPX-dependent cardiomyocyte maturation. Cell Stem Cell 23, 586–598.e8.
Funakoshi, S., Miki, K., Takaki, T., Okubo, C., Hatani, T., Chona- bayashi, K., Nishikawa, M., Takei, I., Oishi, A., Narita, M., et al. (2016). Enhanced engraftment, proliferation, and therapeutic po- tential in heart using optimized human iPSC-derived cardiomyo- cytes. Sci. Rep-uk 6. https://doi.org/10.1038/srep19111.
Garry, D.J., and Olson, E.N. (2006). A common progenitor at the heart of development. Cell 127, 1101–1104.
George, R.M., and Firulli, A.B. (2019). Hand factors in cardiac development. Anat. Rec. (Hoboken) 302, 101–107.
Hemming, M.L., Lawlor, M.A., Zeid, R., Lesluyes, T., Fletcher, J.A., Raut, C.P., Sicinska, E.T., Chibon, F., Armstrong, S.A., Demetri, G.D., et al. (2018). Gastrointestinal stromal tumor enhancers sup- port a transcription factor network predictive of clinical outcome. Proc. Natl. Acad. Sci. U S A 115, E5746–E5755.
Hochgreb, T., Linhares, V.L., Menezes, D.C., Sampaio, A.C., Yan, C.Y., Cardoso, W.V., Rosenthal, N., and Xavier-Neto, J. (2003). A caudorostral wave of RALDH2 conveys anteroposterior informa- tion to the cardiac field. Development 130, 5363–5374.
Jassal, B., Matthews, L., Viteri, G., Gong, C., Lorente, P., Fabregat, A., Sidiropoulos, K., Cook, J., Gillespie, M., Haw, R., et al. (2020). The reactome pathway knowledgebase. Nucleic Acids Res. 48, D498–D503.
Kattman, S.J., Witty, A.D., Gagliardi, M., Dubois, N.C., Niapour, M., Hotta, A., Ellis, J., and Keller, G. (2011). Stage-specific optimiza- tion of activin/nodal and BMP signaling promotes cardiac differen- tiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8, 228–240.
Kel, A., Voss, N., Jauregui, R., Kel-Margoulis, O., and Wingender, E. (2006). Beyond microarrays: finding key transcription factors con- trolling signal transduction pathways. Bmc Bioinformatics 7.
Koschmann, J., Bhar, A., Stegmaier, P., Kel, A.E., and Wingender, E. (2015). Upstream analysis": an integrated promoter-pathway anal- ysis approach to causal interpretation of microarray data. Microar- rays (Basel) 4, 270–286.
Lee, J.H., Protze, S.I., Laksman, Z., Backx, P.H., and Keller, G.M. (2017). Human pluripotent stem cell-derived atrial and ventricular cardiomyocytes develop from distinct mesoderm populations. Cell Stem Cell 21, 179–194.e4.
Li, H.L., Fujimoto, N., Sasakawa, N., Shirai, S., Ohkame, T., Sakuma, T., Tanaka, M., Amano, N., Watanabe, A., Sakurai, H., et al. (2015). Precise correction of the dystrophin gene in Duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. Stem Cell Reports 4, 143–154.
Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E., and Church, G.M. (2013). RNA-guided human genome engineering via Cas9. Science 339, 823–826.
McFadden, D.G., Barbosa, A.C., Richardson, J.A., Schneider, M.D., Srivastava, D., and Olson, E.N. (2005). The Hand1 and Hand2 tran- scription factors regulate expansion of the embryonic cardiac ven- tricles in a gene dosage-dependent manner. Development 132, 189–201.
Meilhac, S.M., and Buckingham, M.E. (2018). The deployment of cell lineages that form the mammalian heart. Nat. Rev. Cardiol. 15, 705–724.
Mills, R.J., Parker, B.L., Quaife-Ryan, G.A., Voges, H.K., Needham, E.J., Bornot, A., Ding, M., Andersson, H., Polla, M., Elliott, D.A., et al. (2019). Drug screening in human PSC-cardiac organoids iden- tifies pro-proliferative compounds acting via the mevalonate pathway. Cell Stem Cell 24, 895–907.e6.
Mohamed, T.M.A., Ang, Y.S., Radzinsky, E., Zhou, P., Huang, Y., El- fenbein, A., Foley, A., Magnitsky, S., and Srivastava, D. (2018). Regulation of cell cycle to stimulate adult cardiomyocyte prolifer- ation and cardiac regeneration. Cell 173, 104–116.e2.
Protze, S.I., Lee, J.H., and Keller, G.M. (2019). Human pluripotent stem cell-derived cardiovascular cells: from developmental biology to therapeutic applications. Cell Stem Cell 25, 311–327.
Randolph, L.N., and Lian, X.L. (2019). Beyond purple hearts: a colorful approach to isolate distinct heart cells from human iPSCs. Cell Stem Cell 24, 675–677.
Reamon-Buettner, S.M., Ciribilli, Y., Inga, A., and Borlak, J. (2008). A loss-of-function mutation in the binding domain of HAND1 pre- dicts hypoplasia of the human hearts. Hum. Mol. Genet. 17, 1397– 1405.
Reamon-Buettner, S.M., Ciribilli, Y., Traverso, I., Kuhls, B., Inga, A., and Borlak, J. (2009). A functional genetic study identifies HAND1 mutations in septation defects of the human heart. Hum. Mol. Genet. 18, 3567–3578.
Riley, P., Anson-Cartwright, L., and Cross, J.C. (1998). The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat. Genet. 18, 271–275.
Risebro, C.A., Smart, N., Dupays, L., Breckenridge, R., Mohun, T.J., and Riley, P.R. (2006). Hand1 regulates cardiomyocyte prolifera- tion versus differentiation in the developing heart. Development 133, 4595–4606.
Rochais, F., Mesbah, K., and Kelly, R.G. (2009). Signaling pathways controlling second heart field development. Circ. Res. 104, 933– 942.
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., and Ben-Ze’ev, A. (1999). The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. U S A 96, 5522–5527.
Singh, M.K., Christoffels, V.M., Dias, J.M., Trowe, M.O., Petry, M., Schuster-Gossler, K., Burger, A., Ericson, J., and Kispert, A. (2005). Tbx20 is essential for cardiac chamber differentiation and repres- sion of Tbx2. Development 132, 2697–2707.
Skelton, R.J., Brady, B., Khoja, S., Sahoo, D., Engel, J., Arasaratnam, D., Saleh, K.K., Abilez, O.J., Zhao, P., Stanley, E.G., et al. (2016). CD13 and ROR2 permit isolation of highly enriched cardiac meso- derm from differentiating human embryonic stem cells. Stem Cell Rep. 6, 95–108.
Srivastava, D., Cserjesi, P., and Olson, E.N. (1995). A subclass of bHLH proteins required for cardiac morphogenesis. Science 270, 1995–1999.
Srivastava, D., Thomas, T., Lin, Q., Kirby, M.L., Brown, D., and Ol- son, E.N. (1997). Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat. Genet. 16, 154–160.
Takaki, T., Inagaki, A., Chonabayashi, K., Inoue, K., Miki, K., Ohno, S., Makiyama, T., Horie, M., and Yoshida, Y. (2020). Optical recording of action potentials in human induced pluripotent stem cell-derived cardiac single cells and monolayers generated from long QT syndrome type 1 patients (vol 2019, 7532657, 2019). Stem Cells Int. 2020.
Takeuchi, T. (2014). Regulation of cardiomyocyte proliferation dur- ing development and regeneration. Dev. Growth Differ. 56, 402– 409.
Togi, K., Kawamoto, T., Yamauchi, R., Yoshida, Y., Kita, T., and Ta- naka, M. (2004). Role of Hand1/eHAND in the dorso-ventral patterning and interventricular septum formation in the embry- onic heart. Mol. Cell Biol. 24, 4627–4635.
Tsankov, A.M., Gu, H., Akopian, V., Ziller, M.J., Donaghey, J., Amit, I., Gnirke, A., and Meissner, A. (2015). Transcription factor binding dynamics during human ES cell differentiation. Nature 518, 344– 349.
Tsuchihashi, T., Maeda, J., Shin, C.H., Ivey, K.N., Black, B.L., Olson, E.N., Yamagishi, H., and Srivastava, D. (2011). Hand2 function in second heart field progenitors is essential for cardiogenesis. Dev. Biol. 351, 62–69.
Vincentz, J.W., Toolan, K.P., Zhang, W., and Firulli, A.B. (2017). Hand factor ablation causes defective left ventricular chamber development and compromised adult cardiac function. PLoS Genet. 13, e1006922.
Woltjen, K., Michael, I.P., Mohseni, P., Desai, R., Mileikovsky, M., Hamalainen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., et al. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766–770.
Wu, S.M., Chien, K.R., and Mummery, C. (2008). Origins and fates of cardiovascular progenitor cells. Cell 132, 537–543.
Yang, L., Soonpaa, M.H., Adler, E.D., Roepke, T.K., Kattman, S.J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G.W., Linden, R.M., et al. (2008). Human cardiovascular progenitor cells develop from a KDR plus embryonic-stem-cell-derived population. Nature 453, 524–U526.
Ye, B., Li, L., Xu, H., Chen, Y., and Li, F. (2019). Opposing roles of TCF7/LEF1 and TCF7L2 in cyclin D2 and Bmp4 expression and car- diomyocyte cell cycle control during late heart development. Lab. Invest. 99, 807–818.
Zhang, J.Z., Termglinchan, V., Shao, N.Y., Itzhaki, I., Liu, C., Ma, N., Tian, L., Wang, V.Y., Chang, A.C.Y., Guo, H.C., et al. (2019). A hu- man iPSC double-reporter system enables purification of cardiac lineage subpopulations with distinct function and drug response profiles. Cell Stem Cell 24, 802.
論文の公開元へ
